Finished Brachytherapy for Cervical Cancer but Still a 2 cm Mass and Daily Discharge? How Long Tumors Keep Shrinking, Which Discharge Is Expected, and When to Go Before Your Follow-Up

A question from a patient group: four brachytherapy sessions done, the doctor says 2 cm remains, and there is fluid every day. Wait for the appointment or go earlier?

The short answer: a mass that can still be measured at the last brachytherapy session does not mean treatment failed, because tumors keep shrinking for months after treatment. If the discharge is clear, odorless, with no fever, no fresh bleeding, and no severe pain, waiting for the scheduled visit is reasonable. If any warning sign below appears, go earlier.

A common question in cervical cancer patient groups: diagnosed at stage 2B, treated with 25 external radiation sessions, 5 cycles of chemotherapy, and 4 brachytherapy sessions. At the end of treatment the doctor said a mass of about 2 cm remained, fluid like discharge comes out every day without blood, and the post-treatment check is about 5–6 weeks away. Should she wait or go earlier? This article summarizes why tumors shrink after treatment ends, when response is assessed, what a remaining mass means, expected versus dangerous discharge, and self-care while waiting. It does not assess any individual case and does not replace advice from the treating doctor.

1. Why is there still a 2 cm mass after the last brachytherapy session? Tumors shrink after treatment ends

The short answer: radiation damages cancer cell DNA, but most cells die when they try to divide, not on the day of treatment. The tumor keeps shrinking for weeks to months after the last session, so a measurement on the final brachytherapy day is not the final result.

Cancer cells die later than the radiation dose

A mechanistic review (Sia 2020) explains that in solid tumors, most radiation-induced cell death happens through mitotic catastrophe: a cell with damaged DNA looks normal for a while, then dies when it tries to divide. Cancer cells do not divide at the same time, so deaths continue after the last dose, and the body then needs time to clear dead cells and repair tissue. That is why tumors shrink more slowly than many people expect.

The measured mass: swelling, scar, or remaining cancer

What a doctor feels or sees after treatment is often a mix of radiation swelling and inflammation, dying cancer cells, scar tissue, and some remaining cancer. In an MRI study of 100 women scanned 1 month after chemoradiation (Park 2016), standard T2 images suggested residual tumor in 41, but adding diffusion-weighted imaging (DWI) reduced this to 22. The 1-year positive predictive value for progression was 32.7% for T2 alone versus 54.4% with DWI. Swelling and scarring often look like tumor early on, but do not assume it is only swelling, because part of it may be real residual cancer.

Evidence: how many months tumors keep shrinking

The BRILACC study (Autorino 2026) followed 79 women with locally advanced cervical cancer treated with chemoradiation and brachytherapy using three MRI scans. The number with no visible tumor rose from 21 at the end of external radiation to 53 at 3 months and 59 at 6 months after brachytherapy. Seven women with a partial response at 3 months had a complete response at 6 months, giving an overall complete clinical response of 80%. The authors recommend waiting about 6 months before a final verdict, to avoid starting extra treatment too early.

Why doctors still take a remaining mass seriously

Saying the remaining mass is all swelling does not match the evidence. An Austrian study (Ebner 2026) biopsied 184 women at the last brachytherapy session and found residual cancer in 46, or 25%. This group had a higher risk of progression (HR 2.03), even when a biopsy 6 weeks later was clear, although overall survival was not significantly different (HR 1.45). In a PET study of 92 women (Schwarz 2007) scanned on average 3 months after treatment, 70% had a complete metabolic response and 16% a partial response, and this scan predicted long-term outcome well. A review (Conte 2023) puts the chance of residual disease beyond 6 months at about 20–30%. The takeaway: an early remaining mass can still shrink, but every follow-up visit matters so that any true residual disease is found early.

Timeline after the last brachytherapy session

Table of the period after the last brachytherapy session, tissue state, expected symptoms, and what doctors usually do. Actual timing varies by hospital (shown as cards on mobile).

2. Clear fluid or discharge every day after brachytherapy: causes, what is expected, and what is dangerous

The short answer: clear, white, or pale-yellow discharge without a foul smell that slowly decreases usually comes from radiation-inflamed lining and shedding tissue. Foul discharge, fever, or urine-like leakage needs a check before the appointment.

Where the discharge comes from

Radiation thins and inflames the vaginal and cervical lining (radiation vaginitis), which weeps more fluid, while treated tissue and dead cancer cells shed. It may contain a little blood or brown tissue fragments. In the EMBRACE study of 588 women (Kirchheiner 2014), mild or worse vaginal symptoms affected 89% and moderate or worse 29% in the first 2 years, mostly starting within 6 months. The most common were narrowing and dryness, while severe vaginal effects occurred in only 3.6%.

What is usually expected and can wait for the appointment

• Clear, white, or pale-yellow discharge without a foul smell that decreases week by week
• Light pink or brown spotting after a pelvic exam, dilator use, or straining, that stops on its own
• Mild irritation or stinging around the vaginal opening from moisture

What needs a check before the appointment

Pus in the uterus (pyometra): after radiation the cervical opening can narrow, so fluid in the uterus cannot drain and becomes infected. In 11,284 women treated with radiation for cervical cancer (Yu 1987), 282, or 2.5%, developed pyometra; the most common organism was E. coli at 46.5%. Warning features are fever above 38 °C, foul pus-like discharge, and lower abdominal pain. It needs drainage and antimicrobial treatment, and doctors often take a biopsy as well.

Fistula: uncommon but important, when constant urine-like leakage keeps you wet, or stool or gas comes from the vagina. In EMBRACE-I (Pötter 2021; Vittrup 2023), the 5-year cumulative rate of severe fistula was 3.2%, and among women whose tumor did not invade the bladder, grade 2 or higher bladder fistula occurred in 0.7% (Spampinato 2021). A US series of 150 women (Ali 2025) found 9%; current smoking was the clearest risk factor (OR 5.14), and fistula symptoms resolved in 62% after treatment.

Triage table for discharge after radiation and brachytherapy, comparing features, possible causes, urgency, and what to do (shown as cards on mobile).

3. Can I wait for the appointment, or should I see a doctor sooner?

The short answer: if the discharge is clear and odorless, with no fever, no fresh bleeding, and no severe pain, you can wait. If any warning sign appears, go earlier, and if you are unsure, call the radiotherapy unit.

Waiting is reasonable when

• Discharge is clear or pale yellow, without a foul smell, and not increasing
• No fever and no chills
• No heavy fresh bleeding, only light spotting that stops on its own
• Mild aching that your prescribed pain medicine relieves
• Urine and stool pass normally, with no urine-like leakage from the vagina

Go before the appointment when

Any symptom in the warning signs section appears, such as fever, foul pus-like discharge, urine-like leakage, stool or gas from the vagina, heavy bleeding, severe pain, one-sided leg swelling, or breathlessness.

Unsure: call first and keep a symptom diary

Most radiotherapy units print a phone number on the appointment card and expect questions after treatment. Asking whether a symptom means the visit should be brought forward is normal. While waiting, note each day the color and smell of discharge, the number of pads, any blood, your temperature, pain, and bowel and bladder habits. These notes help your doctor assess you quickly and accurately at the visit.

4. Five self-care steps after radiation and brachytherapy while you wait

The short answer: gentle hygiene without douching, dilation as your team teaches, enough protein, no smoking, and care for your mind while waiting for results.

1. Gentle hygiene

Wash the outside with clean water once or twice a day, pat dry from front to back, wear loose cotton underwear, and change pads every 3–4 hours or when wet. Do not douche, do not use tampons, and avoid strongly scented soaps or washes, which irritate an already thin lining, unless your treating team prescribes a specific method.

2. Vaginal dilators

Radiation can make the vagina narrower and shorter, which makes pelvic exams difficult and intercourse painful. In EMBRACE-I, 882 women followed for a median of 60 months (Kirchheiner 2025): 64% dilated regularly with a dilator or intercourse and had grade 2 or higher stenosis at 5 years in 23% versus 37% in those who rarely did (HR 0.630), though mild bleeding was more common, 61% versus 34%, which is manageable. A Cochrane review (Miles 2014) found no randomized trials; one report starting dilation 6–10 weeks after radiation found vaginal length increased by a mean of 3 cm, but without a control group. Most teams start once inflammation settles, about 2–8 weeks after treatment. Start only as your radiotherapy team teaches.

3. Sex and dryness

Wait until inflammation settles and ask your doctor at the visit before resuming. When you can, water-based lubricants and vaginal moisturizers help with dryness and pain. Women who were still menstruating before treatment usually enter menopause from radiation, which increases dryness; some doctors consider local estrogen or hormone replacement on an individual basis.

4. Food, fluids, and smoking

Eat protein at every meal, such as eggs, fish, chicken, tofu, or beans, to repair tissue. Drink enough fluids, especially with diarrhea; if radiation diarrhea continues, choose soft, low-fat foods with soluble fiber. Have blood tests as scheduled, because anemia causes fatigue and slows healing. Stop smoking, because smoking was linked to about a 5-fold higher fistula risk (OR 5.14). Supplements or herbs claiming to shrink tumors faster have no supporting evidence, and some affect the liver or blood counts; tell your doctor before using any.

5. Caring for your mind while waiting

Anxiety while waiting for results is very common in people with cancer. Knowing that tumors keep shrinking for months can ease some worry. Walking 15–30 minutes a day, a regular sleep schedule, and talking with family or a patient group help. If you cannot sleep for weeks, feel depressed, or have thoughts of self-harm, tell your doctor or contact a mental health crisis line (1323 in Thailand).

5. Follow-up visits after treatment: what each one checks

The short answer: the first visit after treatment focuses on side effects and a pelvic exam. Imaging to assess response is usually done at about 3–6 months, followed by visits every 3–6 months for the first 2 years.

The first visit after brachytherapy

Usually about 4–8 weeks after treatment. The doctor asks about symptoms, does a pelvic exam if possible, checks bowel, bladder, and vaginal side effects and blood tests, and teaches vaginal care. Feeling firm tissue or a mass at this visit is common, and doctors usually keep watching because it can still shrink.

Imaging to assess response

The ESGO/ESTRO/ESP 2023 guideline recommends assessing response after chemoradiation with a pelvic exam plus imaging such as pelvic MRI and PET-CT or CT at about 3–6 months after treatment. One study (Rajasooriyar 2019) found that of 21 women with a bright spot at the cervix on PET at 6 months, 14 had no disease on a repeat scan 3 months later; and among 15 who had hysterectomy because of suspicion from exam, cytology, or biopsy without PET selection, only 3, or 20%, had residual cancer. A single early scan should not decide everything.

Long-term follow-up

The Society of Gynecologic Oncology (SGO 2017; SGO 2026) states that symptom review, physical and pelvic examination, and teaching patients the warning symptoms are the most effective ways to detect recurrence, typically every 3–6 months for 2 years and every 6–12 months in years 3–5. Routine vaginal cytology or imaging without symptoms adds little, so they are done when indicated.

If disease is still seen after 3–6 months

Doctors usually confirm with a biopsy first. If cancer remains only locally, salvage surgery such as hysterectomy or a larger pelvic operation may be considered. A review of 601 patients (Conte 2023) found residual cancer confirmed in 73% of surgical specimens and severe complications in about 29.8%, so the decision weighs benefit and risk with your gynecologic oncologist. If cancer has spread, the approach is platinum-based chemotherapy with an immune checkpoint inhibitor or an anti-angiogenic drug as appropriate.

6. Comparing options after chemoradiation and brachytherapy: watch, image, treat further, and manage symptoms

The short answer: early after treatment, most care is watching and managing symptoms. Further treatment is considered only when remaining disease is confirmed after an appropriate interval. This table uses drug classes and generic names only.

Comparison table of post-treatment options

Comparison of follow-up exams, imaging, biopsy, further treatment, symptom care, and natural products (shown as cards on mobile).

Frequently Asked Questions (FAQ)

Questions patients and families often ask after chemoradiation and brachytherapy for cervical cancer.

Brachytherapy is finished but the doctor says there is still a 2 cm mass. Does that mean treatment failed?

Not yet. A mass that can still be measured at the last brachytherapy session is common, because most irradiated cancer cells do not die immediately; they die when they try to divide, so the tumor keeps shrinking for weeks to months. A study that biopsied every patient at the last brachytherapy session found residual cancer cells in about 25%, and the BRILACC study found that the number of patients with no tumor on MRI rose from 53 at 3 months to 59 of 79 at 6 months. How well treatment worked is answered at the scheduled follow-up visits.

How long does a cervical tumor take to shrink after chemoradiation and brachytherapy?

Tumors start shrinking during radiation and keep shrinking for several months after treatment ends. The ESGO/ESTRO/ESP 2023 guideline and most studies assess response with MRI or PET-CT about 3–6 months after treatment. In a PET study of 92 women scanned on average 3 months after treatment, 70% had no remaining active disease. In BRILACC, some women with a partial response at 3 months had a complete response at 6 months. The first visit after treatment, usually about 4–8 weeks later, mostly checks side effects and includes a pelvic exam; it is not the final verdict.

Is the size measured after brachytherapy swelling or remaining cancer?

It can be a mix of both: radiation swelling and inflammation, dying cancer cells, scar tissue, and some remaining cancer. Early exams and scans cannot always tell them apart. In an MRI study of 100 women scanned 1 month after treatment, standard T2 images suggested residual tumor in 41, but adding diffusion-weighted imaging (DWI) reduced that to 22, showing that swelling and scarring can look like tumor early on. Do not assume it is only swelling, and do not assume the cancer is resistant; wait for your doctor to reassess on schedule.

What causes clear fluid or discharge every day after brachytherapy, and is it dangerous?

Most often it comes from radiation inflammation of the vaginal and cervical lining, together with shedding of treated tissue and dead cancer cells. Clear, white, or pale-yellow discharge without a foul smell that slowly decreases is expected for several weeks after treatment. In the EMBRACE study of 588 women, mild vaginal symptoms affected 89% in the first 2 years, mostly starting within 6 months. But foul, pus-like discharge, fever, constant urine-like leakage, or stool or gas from the vagina needs a doctor before the follow-up date.

Which symptoms mean I should see a doctor before my follow-up appointment?

Go to the emergency department or call emergency services for vaginal bleeding that soaks a pad within 1 hour or passes large clots, feeling faint, one-sided leg swelling, or sudden breathlessness or chest pain. See a doctor the same day for a fever of 38 degrees Celsius or higher or shaking chills, foul or pus-like discharge, pelvic pain not relieved by your prescribed pain medicine, constant urine-like leakage, stool or gas from the vagina, inability to pass urine, or heavy rectal bleeding. If you are unsure, call the radiotherapy unit number on your appointment card.

How should I care for myself while waiting for the appointment? Should I douche?

Wash the outside gently with clean water once or twice a day, pat dry, wear cotton underwear, and change pads often. Do not douche, do not use tampons, and avoid strongly scented soaps or washes unless your treating team advises a specific method. Eat enough protein, drink enough fluids, and stop smoking, because smoking was linked to about a 5-fold higher risk of fistula. Keep a daily note of color, smell, number of pads, and temperature to show your doctor at the visit.

Do I need a vaginal dilator, and when should I start?

Radiation can make the vagina narrower and shorter, which makes pelvic exams difficult and intercourse painful. In the EMBRACE-I study of 882 women, those who dilated regularly with a dilator or intercourse had grade 2 or higher vaginal stenosis at 5 years in 23% versus 37% in those who rarely did, although mild spotting was more common. A Cochrane review found no randomized trials to confirm the benefit. Most teams start once inflammation settles, usually about 2–8 weeks after treatment; start only when your radiotherapy team teaches and approves it.

If the follow-up still shows a remaining mass, what happens next?

It depends on timing and findings. At the first visit after treatment, doctors usually keep watching because the tumor can still shrink. If imaging at about 3–6 months still shows disease, a biopsy is usually taken to confirm it, and salvage surgery such as hysterectomy or a larger pelvic operation may be considered; a review of 601 patients found severe complications in about 29.8%. If the cancer has spread, chemotherapy and immunotherapy are options. One study found that of 21 women with a bright spot on PET at 6 months, 14 had no disease on a repeat scan 3 months later, so plans should not rest on a single scan.

Scientific mechanism in brief

Summary by Asst. Prof. Dr. Norawit Raatpiboon:
In the FIGO system, stage 2B cervical cancer has spread beyond the cervix into the tissue beside the uterus but not to the pelvic wall. Standard treatment is external radiation of 45–50 Gy in about 25 fractions with weekly cisplatin for 5–6 cycles, followed by brachytherapy. An individual-patient-data analysis of 13 trials (CCCMAC 2010) found that adding chemotherapy to radiation improved 5-year survival by about 6% (HR 0.81), because cisplatin reduces the cancer cells’ ability to repair radiation damage.
Brachytherapy delivers a high dose right next to the tumor, and the dose falls off steeply with distance, so the tumor receives a high dose while the bladder and bowel receive less. In EMBRACE-I, with 1,341 patients (Pötter 2021), MRI-planned brachytherapy achieved 5-year local control of 92%.
Radiation breaks DNA strands; cancer cells that cannot repair the damage die at their next division or within a few divisions, so the tumor keeps shrinking after the last dose. At the same time, radiation damages the lining cells and small blood vessels of the vagina, causing thinning, inflammation, weeping, and shedding early on, then fibrosis that narrows and dries the vagina. Regular dilation helps prevent the vaginal walls from sticking together while that fibrosis forms.

Read next: related guides